Идиопатический легочный фиброз: новые международные клинические рекомендации
Аннотация
Данныеклиническиерекомендацииподиагностикеидиопатическоголегочногофиброза (ИЛФ) явилисьрезультатомсовместной работыАмериканскоготоракального (American Thoracic Society – ATS), Европейскогореспираторного (European Respiratory Society – ERS), Японскогореспираторного (Japanese Respiratory Society – JRS) иЛатиноамериканскоготоракального (Latin American Thoracic Society – ALAT) обществ. Методы. Экспертами многопрофильного комитета по ИЛФ обсуждена доказательная база и сформулированы рекомендации. Проанализированные доказательства и рекомендации сформулированы, написаны и оценены по системе GRADE. Результаты. Экспертами Рабочей группы обновлены диагностические критерии ИЛФ. Ранее описанные паттерны обычной интерстициальной пневмонии (ОИП) уточнены и обозначены как паттерны ОИП, вероятной ОИП, неопределенный и альтернативный диагнозы. Для больных с впервые выявленным интерстициальным заболеванием легких (ИЗЛ) с паттернами вероятной ОИП, неопределенного или альтернативного диагнозов по данным компьютерной томографии легких высокого разрешения (КТВР) разработана условная рекомендация выполнения бронхоальвеолярного лаважа (БАЛ) и хирургической биопсии легких. Рекомендации «за» или «против» выполнения трансбронхиальной биопсии (ТББЛ) или криобиопсии (КБЛ) легких не разработаны по причине недостаточности доказательств. Напротив, для больных с впервые выявленным ИЗЛ и паттерном ОИП по данным КТВР выработана сильная рекомендация НЕ выполнять хирургическую биопсию, ТББЛ и КБЛ; выработана условная рекомендация против использования БАЛ. Дополнительные рекомендации включают условную рекомендацию по многопрофильному обсуждению и сильную рекомендацию против измерения сывороточных биомаркеров с целью дифференциации ИЛФ от других ИЗЛ. Заключение. Экспертами Рабочей группы разработаны рекомендации по диагностике ИЛФ.
Об авторах
С. Н. Авдеев
Первый Московский государственный медицинский университет имени И.М.Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет); Научно-исследовательский институт пульмонологии Федерального медико-биологического агентства
Россия
Россия
Авдеев Сергей Николаевич – доктор медицинских наук, член-корреспондент Российской академии наук, профессор, заведующий кафедрой пульмонологии Первого МГМУ им.И.М.Сеченова (Сеченовский Университет); руководитель клинического отдела НИИ пульмонологии ФМБА.
119991, Москва, ул. Трубецкая, 8, стр. 2; 115682, Москва, Ореховый бульвар, 28.
тел.: (495) 708-35-76
С. Ю. Чикина
Первый Московский государственный медицинский университет имени И.М.Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)
Россия
Россия
Чикина Светлана Юрьевна – кандидат медицинских наук, ассистент кафедры пульмонологии.
119991, Москва, ул. Трубецкая, 8, стр. 2.
тел.: (916) 116-04-03
О. В. Нагаткина
Самарская областная клиническая больница им. В.Д.Середавина
Россия
Россия
Нагаткина Ольга Владимировна – кандидат медицинских наук, врач-пульмонолог I категории.
443095, Самара, ул. Ташкентская, 159.
тел.: (846) 956-23-61
Список литературы
1. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Диагностика и лечение идиопатического легочного фиброза: Федеральные клинические рекомендации. Пульмонология. 2016; 26 (4): 399–419. DOI: 10.18093/0869-0189-2016-26-4-399-419.
2. Thomeer M., Demedts M., Vandeurzen K. et al. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin. Belg. 2001; 56 (3): 163–172. DOI: 10.1179/acb.2001.026.
3. Tinelli C., De Silvestri A., Richeldi L., Oggionni T. The Italian register for diffuse inf iltrative lung disorders (RIPID): a four-year report. Sarcoidosis Vasc. Diffuse Lung Dis. 2005; 22 (Suppl. 1): S4–8.
4. Navaratnam V., Fleming K.M., West J. et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax. 2011; 66 (6): 462–467. DOI: 10.1136/thx.2010.148031.
5. Richeldi L., Rubin A.S., Avdeev S. et al. Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China. BMC Medicine. 2015; 13: 237. DOI: 10.1186/s12916-015-0495-0.
6. Vancheri C., Failla M., Crimi N., Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur. Respir. J. 2010; 35 (3): 496–504. DOI: 10.1183/09031936.00077309.
7. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. Am. J. Respir. Crit. Care Med. 2000; 161 (2, Pt 1): 646–664. DOI: 10.1164/ajrccm.161.2.ats3-00.
8. Raghu G., Collard H.R., Egan J. et al. An off icial ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis; evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183 (6): 788–824. DOI: 10.1164/rccm.2009-040GL.
9. Raghu G., Remy-Jardin M., Myers J.L. et al. Diagnosis of Idiopathic Pulmonary Fibrosis: An Official ATS/ERS/ JRS/ALAT Clinical Practice Guideline. Am. J. Respir. Crit. Care Med. 2018; 198 (5): e44–e68. DOI: 10.1164/rccm.201807-1255ST.
10. Schünemann H.J., Jaeschke R., Cook D.J. et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am. J. Respir. Crit. Care Med. 2006; 174 (5): 605–614. DOI: 10.1164/rccm.200602-197ST.
11. Raghu G., Weycker D., Edelsberg J. et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006; 174 (7): 810–816. DOI: 10.1164/rccm.200602-163OC.
12. Raghu G., Chen S.Y., Yeh W.S. et al. Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11. Lancet Respir. Med. 2014; 2 (7): 566–572. DOI: 10.1016/S2213-2600(14)70101-8.
13. Collard H.R., Ryerson C.J., Corte T.J. et al. Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report. Am. J. Respir. Crit. Care Med. 2016; 194 (3): 265–275. DOI: 10.1164/rccm.201604-0801CI.
14. Nadrous H.F., Myers J.L., Decker P.A., Ryu J.H. Idiopathic pulmonary fibrosis in patients younger than 50 years. Mayo Clin. Proc. 2005; 80 (1): 37–40. DOI: 10.1016/S0025-6196(11)62955-8.
15. Armanios M. Telomerase and idiopathic pulmonary fibrosis. Mutat. Res. 2012; 730 (1): 52–58. DOI: 10.1016/j.mrfmmm.2011.10.013.
16. Behr J., Kreuter M., Hoeper M.M. et al. Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry. Eur. Respir. J. 2015; 46 (1): 186–196. DOI: 10.1183/09031936.00217614.
17. Raghu G., Freudenberger T.D., Yang S. et al. High prevalence of abnormal acid gastro-oesophageal ref lux in idiopathic pulmonary fibrosis. Eur. Respir. J. 2006; 27 (1): 136–142. DOI: 10.1183/09031936.06.00037005
18. Tobin R.W., Pope C.E. 2nd, Pellegrini C.A. et al. Increased prevalence of gastroesophageal ref lux in patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1998; 158 (6): 1804–1808. DOI: 10.1164/ajrccm.158.6.9804105.
19. Patti M.G., Tedesco P., Golden J. et al. Idiopathic pulmonary fibrosis: how often is it really idiopathic? J. Gastrointest. Surg. 2005; 9 (8): 1053–1056. Discussion: 1056–1058. DOI: 10.1016/j.gassur.2005.06.027.
20. Raghu G., Meyer K.C. Silent gastro-oesophageal ref lux and microaspiration in IPF: mounting evidence for antiref lux therapy? Eur. Respir. J. 2012; 39 (2): 242–245. DOI: 10.1183/09031936.00211311.
21. Egan J.J., Stewart J.P., Hasleton P.S. et al. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic f ibrosing alveolitis. Thorax. 1995; 50 (12): 1234–1239. DOI: 10.1136/thx.50.12.1234.
22. Kuwano K., Nomoto Y., Kunitake R. et al. Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur. Respir. J. 1997; 10 (7): 1445–1449. DOI: 10.1183/09031936.97.10071445.
23. Wangoo A., Shaw R.J., Diss T.C. et al. Cryptogenic fibrosing alveolitis: lack of association with Epstein-Barr virus infection. Thorax. 1997; 52 (10): 888–891. DOI: 10.1136/thx.52.10.888.
24. Stewart J.P., Egan J.J., Ross A.J. et al. The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1999; 159 (4, Pt 1): 1336–1341. DOI: 10.1164/ajrc-cm.159.4.9807077
25. Tsukamoto K., Hayakawa H., Sato A. et al. Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax. 2000; 55 (11): 958–961. DOI: 10.1136/tho-rax.55.11.958.
26. Lok S.S., Stewart J.P., Kelly B.G. et al. Epstein-Barr virus and wild p53 in idiopathic pulmonary fibrosis. Respir. Med. 2001; 95 (10): 787–791. DOI: 10.1053/rmed.2001.1152.
27. Kelly B.G., Lok S.S., Hasleton P.S. et al. A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2002; 166 (4): 510–513. DOI: 10.1164/rccm.2103058
28. Tang Y.W., Johnson J.E., Browning P.J. et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J. Clin. Microbiol. 2003; 41 (6): 2633–2640. DOI: 10.1128/jcm.41.6.2633-2640.2003.
29. Zamó A., Poletti V., Reghellin D. et al. HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2005; 22 (2): 123–128.
30. Miyake Y., Sasaki S., Yokoyama T. et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann. Occup. Hyg. 2005; 49 (3): 259–265. DOI: 10.1093/annhyg/meh090.
31. Ueda T., Ohta K., Suzuki N. et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am. Rev. Respir. Dis. 1992; 146 (1): 266–268. DOI: 10.1164/ajrccm/146.1.266.
32. Irving W.L., Day S., Johnston I.D. Idiopathic pulmonary fibrosis and hepatitis C virus infection. Am. Rev. Respir. Dis. 1993; 148 (6, Pt 1): 1683–1684. DOI: 10.1164/ajrc-cm/148.6_Pt_1.1683.
33. Meliconi R., Andreone P., Fasano L. et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax. 1996; 51: 315–317.
34. Yamaguchi S., Kubo K., Fujimoto K. et al. Analysis of bronchoalveolar lavage f luid in patients with chronic hepatitis C before and after treatment with interferon alpha. Thorax. 1997; 52: 33–37. DOI: 10.1136/thx.52.1.33.
35. Idilman R., Cetinkaya H., Savaş I. et al. Bronchoalveolar lavage f luid analysis in individuals with chronic hepatitis C. J. Med. Virol. 2002; 66 (1): 34–39.
36. Arase Y., Ikeda K., Tsubota A. et al. Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus. Hepatol. Res. 2003; 27 (2): 89–94.
37. Raghu G., Amatto V.C., Behr J., Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur. Respir. J. 2015; 46 (4): 1113–1130. DOI: 10.1183/13993003.02316-2014
38. Parry E.M., Alder J.K., Qi X. et al. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011; 117 (21): 5607–5611. DOI: 10.1182/blood-2010-11-322149.
39. Gorgy A.I., Jonassaint N.L., Stanley S.E. et al. Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders. Chest. 2015; 148 (4): 1019–1026. DOI: 10.1378/chest.15-0825.
40. Fingerlin T.E., Murphy E., Zhang W. et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 2013; 45 (6): 613–620. DOI: 10.1038/ng.2609.
41. Peljto A.L., Zhang Y., Fingerlin T.E. et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA. 2013; 309 (21): 2232–2239. DOI: 10.1001/jama.2013.5827.
42. Allen R.J., Porte J., Braybrooke R. et al. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study. Lancet Respir. Med. 2017; 5 (11): 869–880. DOI: 10.1016/S2213-2600(17)30387-9.
43. Newton C.A., Batra K., Torrealba J. et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur. Respir. J. 2016; 48 (6): 1710–1720. DOI: 10.1183/13993003.00308-2016.
44. Borie R., Tabéze L., Thabut G. et al. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis. Eur. Respir. J. 2016; 48 (6): 1721–1731. DOI: 10.1183/13993003.02115-2015.
45. Ley B., Newton C.A., Arnould I. et al. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohortcontrol study. Lancet Respir. Med. 2017; 5 (8): 639–647. DOI: 10.1016/S2213-2600(17)30216-3.
46. Armanios M.Y., Chen J.J., Cogan J.D. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2007; 356 (13): 1317–1326. DOI: 10.1056/NEJMoa066157.
47. Kubo T., Lin P.J.P., Stiller W. et al. Radiation dose reduction in chest CT: a review. Am. J. Roentgenol. 2008; 190 (2): 335–343. DOI: 10.2214/AJR.07.2556.
48. Braun F.M., Johnson T.R., Sommer W.H. et al. Chest CT using spectral filtration: radiation dose, image quality, and spectrum of clinical utility. Eur. Radiol. 2015; 25 (6): 1598–1606. DOI: 10.1007/s00330-014-3559-1.
49. Pontana F., Billard A.S., Duhamel A. et al. Effect of iterative reconstruction on the detection of systemic sclerosis-related interstitial lung diseases: clinical experience in 55 patients. Radiology. 2016; 279 (1): 297–305. DOI: 10.1148/radiol.2015150849.
50. de Margerie-Mellon C., de Bazelaire C., Montlahuc C. et al. Reducing Radiation Dose at Chest CT: Comparison among model-based type iterative reconstruction, hybrid iterative reconstruction and filtered back projection. Acad. Radiol. 2016; 23 (10): 1246–1254. DOI: 10.1016/j.acra.2016.05.019.
51. Miller W.T. Jr, Chatzkel J., Hewitt M.G. Expiratory air trapping on thoracic computed tomography: a diagnostic subclassification. Ann. Am. Thorac. Soc. 2014; 11 (6): 874–881. DOI: 10.1513/AnnalsATS.201311-390OC.
52. Tokura S., Okuma T., Akira M. et al. Utility of expiratory thin-section CT for fibrotic interstitial pneumonia. Acta Radiol. 2014; 55 (9): 1050–1055. DOI: 10.1177/0284185113512300.
53. Kim M., Lee S.M., Song J.W. et al. Added value of prone CT in the assessment of honeycombing and classification of usual interstitial pneumonia pattern. Eur. J. Radiol. 2017; 91: 66–70. DOI: 10.1016/j.ejrad.2017.03.018.
54. Bankier A.A., O’Donnell C.R., Boiselle P.M. Quality initiatives. Respiratory instructions for CT examinations of the lungs: a hands-on guide. Radiographics. 2008; 28 (4): 919–931. DOI: 10.1148/rg.284085035.
55. Hansell D.M., Bankier A.A., MacMahon H. et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology. 2008; 246 (3): 697–722. DOI: 10.1148/radiol.2462070712.
56. Watadani T., Sakai F., Johkoh T. et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology. 2013; 266 (3): 936–944. DOI: 0.1148/radiol.12112516.
57. Lynch D.A., Godwin J.D., Safrin S. et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med. 2005; 172 (4): 488–493. DOI: 10.1164/rccm.200412-1756OC.
58. Sundaram B., Gross B.H., Martinez F.J. et al. Accuracy of high-resolution CT in the diagnosis of diffuse lung disease: effect of predominance and distribution of findings. Am. J. Roentgenol. 2008; 191 (4): 1032–1039. DOI: 10.2214/AJR.07.3177.
59. Goldin J., Elashoff R., Kim H.J. et al. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest. 2009; 136 (5): 1333–1340. DOI: 10.1378/chest.09-0108.
60. Walsh S.L., Sverzellati N., Devaraj A. et al. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur. Radiol. 2012; 22 (8): 1672–1679. DOI: 10.1007/s00330-012-2427-0.
61. Walsh S.L., Sverzellati N., Devaraj A. et al. Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax. 2014; 69 (3): 216–222. DOI: 10.1136/thoraxjnl-2013-203843.
62. Edey A.J., Devaraj A.A., Barker R.P. et al. Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality. Eur. Radiol. 2011; 21 (8): 1586–1593. DOI: 10.1007/s00330-011-2098-2.
63. Sumikawa H., Johkoh T., Colby T.V. et al. Computed tomography f indings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 2008; 177 (4): 433–439. DOI: 10.1164/rccm.200611-1696OC.
64. Remy-Jardin M., Giraud F., Remy J. et al. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology. 1993; 189 (3): 693–698. DOI: 10.1148/radiology.189.3.8234692.
65. Akira M., Kozuka T., Yamamoto S., Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178 (4): 372–378. DOI: 10.1164/rccm.200709-1365OC.
66. Collard H.R., Moore B.B., Flaherty K.R. et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176 (7): 636–643. DOI: 10.1164/rccm.200703-463PP.
67. Hunninghake G.W., Lynch D.A., Galvin J.R. et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest. 2003; 124 (4): 1215–1223. DOI: 10.1378/chest.124.4.1215.
68. Gruden J.F., Panse P.M., Leslie K.O. et al. UIP diagnosed at surgical lung biopsy, 2000–2009: HRCT patterns and proposed classification system. Am. J. Roentgenol. 2013; 200 (5): W458-467. DOI: 10.2214/AJR.12.9437.
69. Tcherakian C., Cottin V., Brillet P.Y. et al. Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease. Thorax. 2011; 66 (3): 226–231. DOI: 10.1136/thx.2010.137190.
70. Johkoh T., Müller N.L., Cartier Y. et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thinsection CT in 129 patients. Radiology. 1999; 211 (2): 555–560. DOI: 10.1148/radiology.211.2.r99ma01555.
71. Hunninghake G.W., Zimmerman M.B., Schwartz D.A. et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2001; 164 (2): 193–196. DOI: 10.1164/ajrccm.164.2.2101090.
72. Nishimura K., Izumi T., Kitaichi M. et al. The diagnostic accuracy of high-resolution computed tomography in diffuse inf iltrative lung diseases. Chest. 1993; 10 4 (4): 1149–1155. DOI: 10.1378/chest.104.4.1149.
73. Mathieson J.R., Mayo J.R., Staples C.A., Müller N.L. Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography. Radiology. 1989; 171 (1): 111–116. DOI: 10.1148/radiology.171.1.2928513.
74. Swensen S.J., Aughenbaugh G.L., Myers J.L. Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. Radiology. 1997; 205 (1): 229–234. DOI: 10.1148/radiology.205.1.9314990.
75. Raghu G., Mageto Y.N., Lockhart D. et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary f ibrosis and other interstitial lung disease: a prospective study. Chest. 1999; 116 (5): 1168–1174. DOI: 10.1378/chest.116.5.1168.
76. Souza C.A., Müller N.L., Lee K.S. et al. Idiopathic interstitial pneumonias: prevalence of mediastinal lymph node enlargement in 206 patients. Am. J. Roentgenol. 2006; 186 (4): 995–999. DOI: 10.2214/AJR.04.1663.
77. Egashira R., Jacob J., Kokosi M.A. et al. Diffuse pulmonary ossification in fibrosing interstitial lung diseases: prevalence and associations. Radiology. 2017; 284 (1): 255–263. DOI: 10.1148/radiol.2017152419.
78. Reddy T.L., von der Thüsen J., Walsh S.L. Idiopathic dendriform pulmonary ossification. J. Thorac. Imag. 2012; 27 (5): W108–110. DOI: 10.1097/RTI.0b013e3182326c38.
79. Reddy T.L., Tominaga M., Hansell D.M. et al. Pleuro-parenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur. Respir. J. 2012; 40 (2): 377–385. DOI: 10.1183/09031936.00165111
80. Chung J.H., Chawla A., Peljto A.L. et al. CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis. Chest. 2015; 147 (2): 450–459. DOI: 10.1378/chest.14-0976.
81. Salisbury M.L., Xia M., Murray S. et al. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis in ILD patients undergoing lung tissue sampling. Respir. Med. 2016; 118: 88–95. DOI: 10.1016/j.rmed.2016.07.016.
82. Brownell R., Moua T., Henry T.S. et al. The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia. Thorax. 2017; 72 (5): 424–429. DOI: 10.1136/thoraxjnl-2016-209671.
83. Raghu G., Wells A.U., Nicholson A.G. et al. Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria. Am. J. Respir. Crit. Care Med. 2017; 195 (1): 78–85. DOI: 10.1164/rccm.201602-0402OC.
84. Yagihashi K., Huckleberry J., Colby T.V. et al. Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia. Eur. Respir. J. 2016; 47 (4): 1189–1197. DOI: 10.1183/13993003.01680-2015.
85. Lynch D.A., Sverzellati N., Travis W.D. et al. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir. Med. 2018; 6 (2): 138–153. DOI: 10.1016/S2213-2600(17)30433-2.
86. Hutchinson J.P., Fogarty A.W., McKeever T.M., Hubbard R.B. In-hospital mortality after surgical lung biopsy for interstitial lung disease in the United States: 2000 to 2011. Am. J. Respir. Crit. Care Med. 2016; 193 (10): 1161–1167. DOI: 10.1164/rccm.201508-1632OC.
87. Flaherty K.R., King T.E. Jr, Raghu G. et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004; 170 (8): 904–910. DOI: 10.1164/rccm.200402-147OC.
88. Singh S., Collins B.F., Sharma B.B. et al. Interstitial lung disease in India: results of a prospective registry. Am. J. Respir. Crit. Care Med. 2017; 195 (6): 801–813. DOI: 10.1164/rccm.201607-1484OC.
89. Salisbury M.L., Myers J.L., Belloli E.A. et al. Diagnosis and treatment of fibrotic hypersensitivity pneumonia: where we stand and where we need to go. Am. J. Respir. Crit. Care Med. 2017; 196 (6): 690–699. DOI: 10.1164/rccm.201608-1675PP.
90. Vasakova M., Morell F., Walsh S. et al. Hypersensitivity pneumonitis: perspectives in diagnosis and management. Am. J. Respir. Crit. Care Med. 2017; 196 (6): 680–689. DOI: 10.1164/rccm.201611-2201PP.
91. Iwai K., Mori T., Yamada N. et al. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am. J. Respir. Crit. Care Med. 1994; 150 (3): 670–675. DOI: 10.1164/ajrccm.150.3.8087336.
92. Hubbard R., Lewis S., Richards K. et al. Occupational exposure to metal or wood dust and aetiology of cryptogenic f ibrosing alveolitis. Lancet. 1996; 347 (8997): 284–289. DOI: 10.1016/s0140-6736(96)90465-1.
93. Baumgartner K.B., Samet J.M., Stidley C.A. et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 1997; 155 (1): 242–248. DOI: 10.1164/ajrccm.155.1.9001319.
94. Johnston I.D., Prescott R.J., Chalmers J.C. et al. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. Thorax. 1997; 52 (1): 38–44. DOI: 10.1136/thx.52.1.38.
95. Hubbard R., Cooper M., Antoniak M. et al. Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet. 2000; 355 (9202): 466–467. DOI: 10.1016/S0140-6736(00)82017-6.
96. Gustafson T., Dahlman-Höglund A., Nilsson K. et al. Occupational exposure and severe pulmonary fibrosis. Respir. Med. 2007; 101 (10): 2207–2212. DOI: 10.1016/j.rmed.2007.02.027.
97. Lega J.C., Reynaud Q., Belot A. et al. Idiopathic inf lammatory myopathies and the lung. Eur. Respir. Rev. 2015; 24 (136): 216–238. DOI: 0.1183/16000617.00002015.
98. Fischer A., Antoniou K.M., Brown K.K. et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur. Respir. J. 2015; 46 (4): 976–987. DOI: 10.1183/13993003.00150-2015.
99. Lee W., Chung W.S., Hong K.S., Huh J. Clinical usefulness of bronchoalveolar lavage cellular analysis and lymphocyte subsets in diffuse interstitial lung diseases. Ann. Lab. Med. 2015; 35 (2): 220–225. DOI: 10.3343/alm.2015.35.2.220.
100. Schildge J., Frank J., Klar B. [The role of bronchoalveolar lavage in the diagnosis of idiopathic pulmonary fibrosis: an investigation of the relevance of the protein content]. Pneumologie. 2016; 70 (7): 435–441. DOI: 10.1055/s-0042-107267 (in German).
101. Nagai S., Kitaichi M., Itoh H. et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J. 1998; 12 (5): 1010–1019. DOI: 10.1183/09031936.98.12051010.
102. Ohshimo S., Bonella F., Cui A. et al. Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179 (11): 1043–1047. DOI: 10.1164/rccm.200808-1313OC.
103. Efared B., Ebang-Atsame G., Rabiou S. et al. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases. J. Negat. Results Biomed. 2017; 16 (1): 4. DOI: 10.1186/s12952-017-0069-0.
104. Welker L., Jörres R.A., Costabel U., Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur. Respir. J. 2004; 24 (6): 1000–1006. DOI: 10.1183/09031936.04.00101303.
105. Ryu Y.J., Chung M.P., Han J. et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir. Med. 2007; 101 (3): 655–660. DOI: 10.1016/j.rmed.2006.06.003.
106. Veeraraghavan S., Latsi P.I., Wells A.U. et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur. Respir. J. 2003; 22 (2): 239–244. DOI: 10.1183/09031936.03.00105202.
107. Ayed A.K. Video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse interstitial lung disease: a prospective study. J. Cardiovasc. Surg. (Torino). 2003; 44 (1): 115–118.
108. Morris D., Zamvar V. The efficacy of video-assisted thoracoscopic surgery lung biopsies in patients with interstitial lung disease: a retrospective study of 66 patients. J. Cardiothorac. Surg. 2014; 9: 45–52. DOI: 10.1186/1749-8090-9-45.
109. Bagheri R., Haghi S.Z., Attaran D. et al. Efficacy of minimally invasive surgery in diagnosis of interstitial lung disease. Asian. Cardiovasc. Thorac. Ann. 2015; 23 (7): 851–854. DOI: 10.1177/0218492315593694.
110. Bando M., Ohno S., Hosono T. et al. Risk of acute exacerbation after video-assisted thoracoscopic lung biopsy for interstitial lung disease. J. Bronchol. Interv. Pulmonol. 2009; 16 (4): 229–235. DOI: 10.1097/LBR.0b013e3181b767cc.
111. Blackhall V., Asif M., Renieri A. et al. The role of surgical lung biopsy in the management of interstitial lung disease: experience from a single institution in the UK. Interact. Cardiovasc. Thorac. Surg. 2013; 17 (2): 253–257. DOI: 10.1093/icvts/ivt217.
112. Blanco M., Obeso G.A., Durán J.C. et al. Surgical lung biopsy for diffuse lung disease: our experience in the last 15 years. Rev. Port. Pneumol. 2013; 19 (2): 59–64. DOI: 10.1016/j.rppneu.2012.11.003.
113. Blewett C.J., Bennett W.F., Miller J.D., Urschel J.D. Open lung biopsy as an outpatient procedure. Ann. Thorac. Surg. 2001; 71 (4): 1113–1115. DOI: 10.1016/s0003-4975(00)02657-6.
114. Fibla J.J., Brunelli A., Allen M.S. et al. Do the number and volume of surgical lung biopsies inf luence the diagnostic yield in interstitial lung disease? A propensity score analysis. Arch. Bronconeumol. 2015; 51 (2): 76–79. DOI: 10.1016/j.arbres.2014.05.011 (in English, Spanish).
115. Findikcioglu A., Karadayi S. Is surgical biopsy necessary for diagnosis of interstitial lung diseases: a retrospective clinical study. J. Clin. Anal. Med. 2014; 5: 204–208.
116. Guerra M., Miranda J.A., Leal F., Vouga L. Interstitial lung disease: diagnostic accuracy and safety of surgical lung biopsy. Rev. Port. Pneumol. 2009; 15 (3): 433–442 (in English, Portuguese).
117. Ishie R.T., Cardoso J.J.D., Silveira R.J., Stocco L. Video-assisted thoracoscopy for the diagnosis of diffuse parenchymal lung disease. J. Bras. Pneumol. 2009; 35 (3): 234–241 (in English, Portuguese).
118. Kayatta M.O., Ahmed S., Hammel J.A. et al. Surgical biopsy of suspected interstitial lung disease is superior to radiographic diagnosis. Ann. Thorac. Surg. 2013; 96 (2): 399–401. DOI: 10.1016/j.athoracsur.2013.04.065.
119. Khalil M., Cowen M., Chaudhry M., Loubani M. Single versus multiple lung biopsies for suspected interstitial lung disease. Asian Cardiovasc. Thorac. Ann. 2016; 24 (8): 788–791. DOI: 10.1177/0218492316665551.
120. Kreider M.E., Hansen-Flaschen J., Ahmad N.N. et al. Complications of video-assisted thoracoscopic lung biopsy in patients with interstitial lung disease. Ann. Thorac. Surg. 2007; 83 (3): 1140–1144. DOI: 10.1016/j.athoracsur.2006.10.002.
121. Luo Q., Han Q., Chen X. et al. The diagnosis efficacy and safety of video-assisted thoracoscopy surgery (VATS) in undefined interstitial lung diseases: a retrospective study. J. Thorac. Dis. 2013; 5 (3): 283–288. DOI: 10.3978/j.issn.2072-1439.2013.04.12.
122. Miller J.D., Urschel J.D.A., Cox G. et al. A randomized, controlled trial comparing thoracoscopy and limited thoracotomy for lung biopsy in interstitial lung disease. Ann. Thorac. Surg. 2000; 70 (5): 1647–1650. DOI: 10.1016/s0003-4975(00)01913-5.
123. Ooi A., Iyenger S., Ferguson J., Ritchie A.J. VATS lung biopsy in suspected, diffuse interstitial lung disease provides diagnosis, and alters management strategies. Heart Lung Circ. 2005; 14 (2): 90–92. DOI: 10.1016/j.hlc.2005.01.002.
124. Pompeo E., Rogliani P., Cristino B. et al. Awake thoracoscopic biopsy of interstitial lung disease. Ann. Thorac. Surg. 2013; 95 (2): 445–452. DOI: 10.1016/j.athoracsur.2012.10.043.
125. Qureshi R.A., Ahmed T.A., Grayson A.D. et al. Does lung biopsy help patients with interstitial lung disease? Eur. J. Cardiothorac. Surg. 2002; 21 (4): 621–626; discussion 626. DOI: 10.1016/s1010-7940(02)00021-0.
126. Rotolo N., Imperatori A., Dominioni L. et al. Efficacy and safety of surgical lung biopsy for interstitial disease: experience of 161 consecutive patients from a single institution in Italy. Sarcoidosis Vasc. Diffuse Lung Dis. 2015; 32 (3): 251–258.
127. Samejima J., Tajiri M., Ogura T. et al. Thoracoscopic lung biopsy in 285 patients with diffuse pulmonary disease. Asian Cardiovasc. Thorac. Ann. 2015; 23 (2): 191–197. DOI: 10.1177/0218492314550724.
128. Sigurdsson M.I., Isaksson H.J., Gudmundsson G., Gudbjartsson T. Diagnostic surgical lung biopsies for suspected interstitial lung diseases: a retrospective study. Ann. Thorac. Surg. 2009; 88 (1): 227–232. DOI: 10.1016/j.athoracsur.2009.04.002.
129. Sonobe M., Handa T., Tanizawa K. et al. Videothoracoscopy-assisted surgical lung biopsy for interstitial lung diseases. Gen. Thorac. Cardiovasc. Surg. 2014; 62 (6): 376–382. DOI: 10.1007/s11748-014-0383-0.
130. Tomassetti S., Wells A.U., Costabel U. et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2016; 193 (7): 745–752. DOI: 10.1164/rccm.201504-0711OC.
131. Ravaglia C., Bonifazi M., Wells A.U. et al. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration. 2016; 91 (3): 215–227. DOI: 10.1159/000444089.
132. Morell F., Reyes L., Doménech G. et al. [Diagnoses and diagnostic procedures in 500 consecutive patients with clinical suspicion of interstitial lung disease]. Arch. Bronconeumol. 2008; 44 (4): 185–191 (in Spanish).
133. Raghu G., Rochwerg B., Zhang Y. et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am. J. Respir. Crit. Care Med. 2015; 192 (2): e3–e19. DOI: 10.1164/rccm.201506-1063ST.
134. Han Q., Luo Q., Chen X. et al. The evaluation of clinical usefulness of transbrochoscopic lung biopsy in undefined interstitial lung diseases: a retrospective study. Clin. Respir. J. 2017; 11 (2): 168–175. DOI: 10.1111/crj.12318.
135. Sindhwani G., Shirazi N., Sodhi R. et al. Transbronchial lung biopsy in patients with diffuse parenchymal lung disease without ‘idiopathic pulmonary fibrosis pattern’ on HRCT scan: experience from a tertiary care center of North India. Lung India. 2015; 32 (5): 453–456. DOI: 10.4103/0970-2113.164148.
136. Sheth J.S., Belperio J.A., Fishbein M.C. et al. Utility of transbronchial vs surgical lung biopsy in the diagnosis of suspected fibrotic interstitial lung disease. Chest. 2017; 151 (2): 389–399. DOI: 10.1016/j.chest.2016.09.028.
137. Pajares V., Puzo C., Castillo D. et al. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology. 2014; 19 (6): 900–906. DOI: 10.1111/resp.12322.
138. Pourabdollah M., Shamaei M., Karimi S. et al. Transbronchial lung biopsy: the pathologist’s point of view. Clin. Respir. J. 2014;10 (2): 211–216. DOI: 10.1111/crj.12207.
139. Ramaswamy A., Homer R., Killam J. et al. Comparison of transbronchial and cryobiopsies in evaluation of diffuse parenchymal lung disease. J. Bronchology Interv. Pulmonol. 2016; 23 (1): 14–21. DOI: 10.1097/LBR.0000000000000246.
140. Kim S.Y., Diggans J., Pankratz D. et al. Classification of usual interstitial pneumonia in patients with interstitial lung disease: assessment of a machine learning approach using high-dimensional transcriptional data. Lancet Respir. Med. 2015; 3 (6): 473–482. DOI: 10.1016/S2213-2600(15)00140-X.
141. Pankratz D.G., Choi Y., Imtiaz U. et al. Usual interstitial pneumonia can be detected in transbronchial biopsies using machine learning. Ann. Am. Thorac. Soc. 2017; 14 (11): 1646–1654. DOI: 10.1513/AnnalsATS.201612-947OC.
142. Cascante J.A., Cebollero P., Herrero S. et al. Transbronchial cryobiopsy in interstitial lung disease: are we on the right path? J. Bronchology Interv. Pulmonol. 2016; 23 (3): 204–209. DOI: 10.1097/LBR.0000000000000292.
143. Fruchter O., Fridel L., El Raouf B.A. et al. Histological diagnosis of interstitial lung diseases by cryo-transbronchial biopsy. Respirology. 2014; 19 (5): 683–688. DOI: 10.1111/resp.12296.
144. Griff S., Schönfeld N., Ammenwerth W. et al. Diagnostic yield of transbronchial cryobiopsy in non-neoplastic lung disease: a retrospective case series. BMC Pulm. Med. 2014; 14: 171. DOI: 10.1186/1471-2466-14-171.
145. Hagmeyer L., Theegarten D., Treml M. et al. Validation of transbronchial cryobiopsy in interstitial lung disease – interim analysis of a prospective trial and critical review of the literature. Sarcoidosis Vasc. Diffuse Lung Dis. 2016; 33 (1): 2–9.
146. Hernández-González F., Lucena C.M., Ramírez J. et al. Cryobiopsy in the diagnosis of diffuse interstitial lung disease: yield and cost-effectiveness analysis. Arch. Bronconeumol. 2015; 51 (6): 261–267. DOI: 10.1016/j.arbres.2014.09.009 (in English, Spanish).
147. Kronborg-White S., Folkersen B., Rasmussen T.R. et al. Introduction of cryobiopsies in the diagnostics of interstitial lung diseases – experiences in a referral center. Eur. Clin. Respir. J. 2017; 4 (1): 1274099. DOI: 10.1080/20018525.2016.1274099.
148. Kropski J.A., Pritchett J.M., Mason W.R. et al. Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease. PLoS One. 2013; 8 (11): e78674. DOI: 10.1371/journal.pone.0078674.
149. Pourabdollah M., Shamaei M., Karimi S. et al. Transbronchial lung biopsy: the pathologist’s point of view. Clin. Respir. J. 2016; 10 (2): 211–216. DOI: 10.1111/crj.12207.
150. Ussavarungsi K., Kern R.M., Roden A.C. et al. Transbronchial cryobiopsy in diffuse parenchymal lung disease: retrospective analysis of 74 cases. Chest. 2017; 151 (2): 400–408. DOI: 10.1016/j.chest.2016.09.002.
151. Sharp C., McCabe M., Adamali H., Medford A.R. Use of transbronchial cryobiopsy in the diagnosis of interstitial lung disease: a systematic review and cost analysis. QJM. 2017; 110 (4): 207–214. DOI: 10.1093/qjmed/hcw142.
152. Ganganah O., Guo S.L., Chiniah M., Li Y.S. Efficacy and safety of cryobiopsy versus forceps biopsy for interstitial lung diseases and lung tumours: a systematic review and meta-analysis. Respirology. 2016; 21 (5): 834–841. DOI: 10.1111/resp.12770.
153. Hetzel J., Maldonado F., Ravaglia C. et al. Transbronchial cryobiopsies for the diagnosis of diffuse parenchymal lung diseases: expert statement from the Cryobiopsy Working Group on Safety and Utility and a call for standardization of the procedure. Respiration. 2018; 95 (3): 188–200. DOI: 10.1159/000484055.
154. Chaudhuri N., Spencer L., Greaves M. et al. A review of the multidisciplinary diagnosis of interstitial lung diseases: a retrospective analysis in a single UK specialist centre. J. Clin. Med. 2016; 5 (8): pii: E66. DOI: 10.3390/jcm5080066.
155. Thomeer M., Demedts M., Behr J. et al. Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur. Respir. J. 2008; 31 (3): 585–591. DOI: 10.1183/09031936.00063706.
156. Jo H.E., Glaspole I.N., Levin K.C. et al. Clinical impact of the interstitial lung disease multidisciplinary service. Respirology. 2016; 21 (8): 1438–1444. DOI: 10.1111/resp.12850.
157. Theegarten D., Müller H.M., Bonella F. et al. Diagnostic approach to interstitial pneumonias in a single centre: report on 88 cases. Diagn. Pathol. 2012; 7: 160. DOI: 10.1186/1746-1596-7-160.
158. White E.S., Xia M., Murray S. et al. Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2016; 194 (10): 1242–1251. DOI: 10.1164/rccm.201505-0862OC.
159. Morais A., Beltrão M., Sokhatska O. et al. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias. Respir. Med. 2015; 109 (8): 1063–1068. DOI: 10.1016/j.rmed.2015.06.003.
Для цитирования:
Авдеев С.Н., Чикина С.Ю., Нагаткина О.В. Идиопатический легочный фиброз: новые международные клинические рекомендации. Пульмонология. 2019;29(5):525-552. https://doi.org/10.18093/0869-0189-2019-29-5-525-552
For citation:
Avdeev S.N., Chikina S.Yu., Nagatkina O.V. Idiopathic pulmonary fibrosis: a new international clinical guideline. PULMONOLOGIYA. 2019;29(5):525-552. (In Russ.) https://doi.org/10.18093/0869-0189-2019-29-5-525-552
Просмотров: 2262
Послать статью по эл. почте 